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Abstract
Toll-like receptor 9 (TLR9) activates the innate immune system in response to oligonucleotides rich in CpG whereas DNA
lacking CpG could inhibit its activation. However, the mechanism of how TLR9 interacts with nucleic acid and becomes
activated in live cells is not well understood. Here, we report on the successful implementation of single molecule tools,
constituting fluorescence correlation/cross-correlation spectroscopy (FCS and FCCS) and photon count histogram (PCH)
with fluorescence lifetime imaging (FLIM) to study the interaction of TLR9-GFP with Cy5 labeled oligonucleotide containing
CpG or lacking CpG in live HEK 293 cells. Our findings show that i) TLR9 predominantly forms homodimers (80%) before
binding to a ligand and further addition of CpG or non CpG DNA does not necessarily increase the proportion of TLR9
dimers, ii) CpG DNA has a lower dissociation constant (62 nM69 nM) compared to non CpG DNA (153 nM626 nM) upon
binding to TLR9, suggesting that a motif specific binding affinity of TLR9 could be an important factor in instituting a
conformational change-dependant activation, and iii) both CpG and non CpG DNA binds to TLR9 with a 1:2 stoichiometry in
vivo. Collectively, through our findings we establish an in vivo model of TLR9 binding and activation by CpG DNA using
single molecule fluorescence techniques for single cell studies.
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Introduction
Toll-like receptors (TLRs), one of the pattern-recognition
receptors (PRRs), are the key sensors of microbial infection in
mammals [1,2]. Human TLRs have been identified with different
sub-cellular localizations and have been found to recognize a wide
array of molecules comprising of lipopolysaccharides and nucleic
acids [3,4,5,6]. TLR9 is thought to be able to activate the innate
immune system by detecting unmethylated CpG dinucleotides,
which are common in the genomes of most bacterial and DNA
viruses, but which are suppressed and methylated in vertebrate
genomes [7]. Ligand binding to TLR9 results in the recruitment of
adaptor proteins, MyD88, to ultimately lead to the activation of
NF-kB, a key regulator of many inflammatory response pathways
[8]. MyD88 has a C-terminal Toll/IL-1R (TIR) containing
portion that associates with the TLR-TIR domain and an
intermediate domain (ID) that is crucial in TLR signaling since
it interacts with IL-1R associated kinases (IRAKs) [9].
Although the prevailing paradigm attributes the activation of
TLR9 to the recognition of CpG containing DNA, reports present
different explanation on the ability of TLR9 to discriminate
nucleic acids based on in vitro studies. Rutz et al. found that TLR9
interacts with nucleic acids in a sequence-specific manner [10]
while others report that TLR9 binds to nucleic acids in a
sequence-independent manner [11,12,13]. It was further demon-
strated that binding to CpG DNA could induce conformational
changes and subsequently reduce the diameter of the extracellular
domain [14]. However, all of these investigations relating to the
interaction of TLR9 with nucleic acids are based upon in vitro
assay, no report has examined such interactions in live cells. Tools
to elucidate TLR9 activation or inactivation in vivo have the
potential to broadly impact TLR9 biology and assist in the
development of more effective therapeutics.
Since most of the past attempts use traditional biochemical
techniques, which generally require the disruption of natural
cellular compartments, interrogation of the intracellular kinetics
was not possible. Single molecule fluorescence techniques such as
fluorescence correlation/cross-correlation spectroscopy (FCS/
FCCS) and photon counting histogram (PCH) provides a high
spatial and temporal resolution for direct quantitative investigation
of molecular dynamics in live cells. FCS allows for the non-
invasive in vivo monitoring of the diffusion time (tD) and the
absolute concentration of fluorescing probes diffusing through the
confocal volume (, 1fL) [15,16,17]. While FCS examines the
autocorrelation of fluorescence from a single species, FCCS
examines the fluorescence signal from two species simultaneously
through cross-correlation to provide quantitative information of
the number of molecules and their interaction [18,19,20]. PCH
could be used to evaluate molecular brightness (expressed as
counts per second per molecule, cpsm) to estimate the stoichiom-
etry (monomers, dimers, trimers, etc) [21,22] of the diffusers from
fluorescence fluctuation data.
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e17991In this study, we combine FCS/FCCS, PCH and fluorescence
lifetime imaging (FLIM) to investigate the interaction of DNA
containing CpG or lacking CpG in HEK 293 cells expressing
TLR9-GFP. Through quantitative PCH analysis, we find that
TLR9 predominantly forms homodimers before binding to the
nucleic acids and the percentage of dimers does not change upon
interaction with either CpG or non CpG DNA. Through FCS we
reveal that CpG-TLR9 complex has different diffusion dynamics
compared to non CpG-TLR9. With FCCS we further observe
that both CpG and non CpG DNA binds to TLR9 in a 1:2
stoichiometry in vivo but with different affinity. While the
integrated approach used in this study provides a noninvasive
and quantitative means to understand TLR9 and nucleic acid
interactions in vivo, the demonstrated single molecule analysis tools
in single cells can be extended for studies with other protein-ligand
interaction in live cells.
Results
PCH analysis reveals TLR9 forms homodimers in live cells
The formation of higher order oligomers possibly representing a
conserved mechanism of activation has been demonstrated as a
signaling prerequisite for a number of TLRs [23,24]. Cells
expressing GFP and TLR9-GFP were first used to determine the
oligomeric status of TLR9. Fluorescence lifetime imaging (FLIM)
was performed to show the distribution of GFP and TLR9-GFP
(Supporting information (SI), Figure S1). Unlike GFP, which was
found to be distributed throughout the cells, the expression pattern
of TLR9-GFP was found to be distributed in specific intracellular
compartments (SI, Figure S1a). Past studies have shown that
TLR9 is localized within the endoplasmic reticulum (ER) and
endosome [25]. Since fluorescence lifetime is sensitive to the
physico-chemical environment such as the membrane potential,
pH and osmotic conditions [26,27], lifetime analysis can be used to
assess biomolecular interactions and localization of targets in
different microenvironments. Fluorescence lifetime imaging
(FLIM) is a powerful method for separating species based on
differences in the exponential decay rate of fluorescence,
independent of intensity. In our experiments, the average lifetime
of GFP (2.3 ns60.02 ns) and TLR9-GFP (2.9 ns60.03 ns) was
determined by fitting the time correlated single photon counting
(TCSPC) data with Eq.1 (single component, i=1). The change in
lifetime could suggest that TLR9 is predominantly distributed in
the endosomal compartments whose microenvironment compris-
ing of cargos, pH, structure among others is different from that of
the cytosol.
To demonstrate the stoichiometry, HEK 293 cells were first
constructed to transiently express CFP and CFP-CFP constructs
(Insets, Figure 1c). PCH data (Figure 1b) of CFP and CFP-CFP
expressions could be fitted well with single component (i=1,
x
2=1.32) using a very low excitation power (8 mw) to minimize
photobleaching. Our results show that the brightness of CFP-CFP
(2430 cpsm6375 cpsm) dimers was roughly twice that of CFP
(5210 cpsm6636 cpsm), as expected, providing the basis for
stoichiometry and quantification. Average brightness of GFP
alone as determined by the single component (i=1) fitting of GFP
transfected cells (Figure 2a) was 1689 cpsm6321 cpsm. In
contrast, PCH analysis of TLR9-GFP could be fitted (x
2=1.1)
with two components (I=2) instead of one component (i=1,
x
2=5.3). While the brightness of one segment of the population
was similar to that of GFP monomers, the brightness of the other
segment of the population was close to twice this value suggesting
that TLR9 could homodimerize before binding to a CpG ligand.
The formation of higher order oligomers of TLR9 was ruled out
Figure 1. Single molecule fluorescence tools to probe TLR9 interaction in live cells. (a) The fluorescence fluctuation data was analyzed
using the auto/cross-correlation by FCS/FCCS or PCH/2dPCH to estimate the diffusion dynamics, number of molecules, and stoichiometry. (b) Photon
counting histogram (PCH) analysis of CFP (open red squares) and CFP-CFP (open black circles) constructs. (c) Calculated brightness of CFP and CFP-
CFP dimer from PCH analysis. Error bars are standard deviation (n=10). Insets are the images of HEK 293 cells transiently transfected with CFP and
CFP-CFP dimer.
doi:10.1371/journal.pone.0017991.g001
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GFP was less than thrice that of monomers. Our results are
consistent with the previous in vitro studies using co-immunopre-
cipitation and FRET experiments [14]. Furthermore, by global
fitting of PCH data we determine that 79.1%65.1% of the TLR9
forms dimers and the rest exist as monomers and the fraction of
TLR9 dimers did not change (p=0.8) upon addition of CpG
(82.6%66.1%) or non-CpG DNA (82.6%64.3%) (Figure 2b).
Considering the fact that TLR9 activation was restricted to
phosphorothioate (PS) CpG-motif DNA [12,13,14], our findings
suggest that its activation is not associated with CpG DNA
induced formation of dimer or higher order oligomers, and
additional prerequisites might be necessary for its activation.
TLR9 binding to CpG and non CpG DNA with different
affinity
To investigate whether binding affinity plays an important role
in TLR9 activation, we employed FCCS to evaluate the
dissociation constant of TLR9 using different DNA sequences,
in vivo. Confocal fluorescence images (Figure 3a,c) show that both
CpG and non CpG DNA colocalize with TLR9-GFP, indicating
a possible interaction at these regions and to provide a potential
point of focus for the assessment of stoichiometry and binding
kinetics. As noted earlier, with FCCS it is possible to evaluate the
diffusion of two species in a focal volume by monitoring fluo-
rescence fluctuation intensity (Figure 1a), where the amplitude of
the cross-correlation provides the respective concentration of the
interacting species in the complex. From the amplitude
(Figure 3b,d) of the FCS and FCCS measurements, the
concentration and diffusion time of TLR9, CpG or non CpG
DNA and the respective bound complexes was calculated. Positive
cross-correlation was obtained for both CpG and non CpG DNA
bound to TLR9 and their respective dissociation constants (Kd)
were calculated in living cells using the equation, [TLR9][DNA]/
[TLR9-DNA], where [TLR9] and [DNA] denote the respective
concentrations of TLR9 dimers and nucleic acids. [TLR9-DNA]
represents the concentration of the bound complexes. Using
single molecule experiments we provide a quantitative estimate of
their interactions in single cells. Calculations show that the
binding affinity of TLR9 with CpG DNA (Kd=62nmol/
L69 nmol/L) was higher (p,0.01) than that of TLR9 with non
CpG DNA (Kd=153 nmol/L626 nmol/L) from our live single
cell experiments.
Mobility of TLR9-Ligand complex by FCS
Since different binding affinities were noted for CpG and non
CpG DNA upon binding to TLR9, we predicted that CpG-
TLR9 and non CpG-TLR9 bound complex might have different
intracellular mobilities. To examine the diffusion dynamics of
TLR9, the diffusion time of GFP was compared with TLR9-GFP
using FCS. As expected, the diffusion time of TLR9-GFP was
1.78 ms, which is greater than that of cytosolic GFP (diffusion
time was 0.47 ms) at the 95% confidence limit (p,0.05). In
addition, show that cytosolic GFP could be best fitted with a 3D
diffusion model while the TLR9-GFP could be best fitted by an
anomalous model used to describe the diffusion of particles
hindered by obstacles or subject to an external force (SI, Figure
S2). The anomalous diffusion exponent ‘a’ was found to be 0.35
for TLR9 which decreased in proportion to an increase in
concentration of obstacles posed by intracellular constituents
[28]. This value was higher than the observed value (a=0.75) for
protein [28] or lipid granules [29] diffusing in the cytoplasm,
possibly due to the predominant distribution of TLR9 in the
endosomes/lysosomes.
From FCCS measurements, the concentration of the interacting
species in the complex was calculated to provide an estimate of the
fraction of CpG-TLR9 or non CpG-TLR9 complexes formed
relative to the lower concentration of the partner (Eq. 9). Our
results show that the population consisted of over 62%611.2% of
CpG DNA-TLR9 constructs compared to 32%65.7% of non
CpG DNA-TLR9 (Figure 4a) complexes in live cells (p,0.05).
The diffusion characteristics of the bound complex were then
calculated from FCS data using the maximum entropy method
(MEMFCS)[30], which attempts to minimize the normalized chi-
square value x
2 while maximizing the entropy ‘S’ in the
calculations. Unlike conventional methods where fitting compo-
nents need to be assigned an initial value, MEMFCS does not
need an initial value. Further, fitting a heterogeneous population
of diffusers is possible because this analysis yields a diffusion time
distribution that represents a heterogeneous population. From
MEMFCS we show that the CpG-TLR9 complex (peak position
at 2.9 ms) has a longer diffusion time compared to non CpG-
TLR9 (peak position at 1.6 ms) at the 95% level (p,0.05)
(Figure 4b), indicating a possible increase in its size due to the
recruitment of MyD88 and subsequent signaling complex
comprising of TRAF6 (tumour-necrosis factor (TNF)-receptor-
associated factor 6), BTK (Bruton’s tyrosine kinase), IRAK4
(interleukin-1-receptor (IL-1R)-associated kinase 4) and IRAK1to
initiate signaling [31,32].
Figure 2. PCH analysis of TLR9-GFP dimers in live cells. (a)
Brightness values of autofluorescence (Auto), GFP and TLR9-GFP
obtained under identical experimental conditions by PCH analysis
(n=12). Blue and red line represent mean brightness counts of
autofluorescence and GFP monomer brightness. Black line denotes
the predicted brightness of GFP dimers. (b) Percentage of monomer
and dimers in TLR9-GFP alone, TLR9 incubated with CpG DNA and TLR9
incubated with non-CpG DNA, quantified by PCH data. Error bars are
standard deviation (n=12).
doi:10.1371/journal.pone.0017991.g002
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While FCCS could provide information on concentration and
diffusion time of bound molecules, two-dimensional PCH (2dPCH),
an extension of regular PCH (ie. 1dPCH) developed in this work
[22], is uniquely suited to provide stoichiometry information of the
complex, based on its brightness information using photon counts
from the two detector channels. Furthermore, since the instrument
setup of 2dPCH is identical to FCCS, the fluorescence fluctuation
raw data could be used for both FCCS and 2dPCH analysis. Since
each detection channel records its own color of light, the 2dPCH
distinguishes fluorescent species not only based on the differences in
their brightness, but also according to their color for stoichiometry
analysis [33,34]. The 2dPCH histograms of CpG-TLR9 and non
CpG-TLR9 complexes could be fitted well with a single component
(i=1, x
2=1.43) using the respective brightness values of the
diffusing particles recorded in the green and red channels. The data
shows that both the CpG-TLR9 and non CpG-TLR9 complexes
have an average brightness (CpG-TLR9: 11886 cpsm61169 cpsm,
non CpG-TLR9: 12452 cpsm61320 cpsm) comparable to that of
Cy5 monomers in red channel and an average brightness similar to
GFP-GFP dimers in the green channel (Figure 5), suggesting a 2:1
(TLR-GFP:DNA-Cy5) binding stoichiometry for both CpG-TLR9
and non CpG-TLR9 complexes in live cells.
Discussion
Traditional biochemical assay such as co-immunoprecipitation
or pull down experiments are valuable tools for studying protein-
protein or protein-DNA interactions. However, these approaches
require the disruption and cell lysis to extract the protein of
interest. Single molecule fluorescence techniques demonstarted
have the ability to provide quantitative estimates of biomolecular
interactions without disrupting the partnering molecules at high
spatial and temporal resolution. Consequently, the work presented
here successfully combines FCCS and PCH and FLIM to assess
the intracellular localization, binding affinity, mobility, and
composition of TLR9 and its ligands by estimating the diffusion
time, number of molecules, fluorescence lifetime, brightness and
stoichiometry of interaction (Figure 1a) in live single cells.
We first use PCH analysis to investigate TLR9 oligomerization
before and after its interaction with DNA. By characterizing the
amplitude of fluorescence fluctuations, PCH provides two
estimates, the number of particles (N) and molecular brightness
(e). Molecular brightness (e), defined as the average number of
photons per molecule per second, is an inherent property of the
fluorescence molecule that is not related to concentration and
could provide a ‘‘brightness signature’’ to separate different species
[21]. Therefore, one would expect the dimer constructs to
approximately measure twice the brightness values of monomers.
From our experiments, we observed that TLR9 predominantly
forms dimers prior to binding to a ligand. By quantitatively
estimating the fraction of bound complex, we found that the
percentage of dimers formed did not change irrespective of the
interacting partner, either the CpG or non CpG DNA (Figure 2b).
Previous in vitro experiments confirmed that CpG containing
nucleic acids could activate the downstream signaling of TLR9 by
bringing the cytoplasmic domains in close proximity while non
CpG could not induce conformational changes [14]. Our results
show that formation of dimers was not sufficient for the activation
of TLR9 and an additional prerequisite for activation constituting
a change in structural conformation might be necessary. This
mechanism is different from TLR3, which is capable of binding to
double stranded RNA (dsRNA), to exclusively form monomer
constructs in solution but in most instances forms dimers when
bound to dsRNA through a highly cooperative processes [35].
These results suggest that the activation and binding model could
be different for each TLRs because their ligands are fundamen-
tally different. Future studies on in vivo binding to other TLRs will
be essential for understanding the biology of TLRs and their
interacting partners.
Since we have demonstrated that the percentage of TLR9
predimers did not increase upon addition of CpG or non CpG
DNA, the binding affinity of TLR9 to different DNA motifs might
play an important role in its activation. Using fluorescence
Figure 3. Cross-correlation analysis of TLR9 with CpG and non CpG DNA. Confocal fluorescence image of (a) TLR9-GFP (left) with CpG DNA
(right) and (c) TLR9-GFP (left) with non CpG DNA (right). Scale bar: 10 mm. Autocorrelation (Blue and red) and cross-correlation (black) curves from
FCCS measurement confirms the in vivo binding between TLR9 and CpG (b) or non CpG DNA (d). Curves represent an average of 30 different
measurements across 10–30 different cells.
doi:10.1371/journal.pone.0017991.g003
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CpG DNA as 62 nmol/L69 nmol/L while that of non CpG
DNA was 153 nmol/L626 nmol/L. Our observation is expect-
edly different from the previous in vitro [14] work which reported a
value in the range of 1–10 nmol/L, possibly attributable to the
intracellular microenvironment and the association of TLR9 with
other proteins for downstream signal activation upon binding to
CpG DNA. While past studies show that TLR9 activation and
signaling driven by CpG DNA requires acidification and
maturation of endosomes [36], the acidic pH could serve as an
optimal condition for interaction and could contribute to the
difference in the in vitro and in vivo binding affinity estimates. Given
the fact that the activation of TLR9 involves ligand-induced
conformational changes to the TLR9 homodimers, our results
suggests that TLR9 conformational change and activation was
induced by CpG DNA and not by non CpG DNA because of a
significant difference in the dissociation constant values obtained
from our in vivo single molecule experiments. It is worth noting that
the fusion of GPF to TLR9 will not adversely affect its interaction
with the CpG nucleotides because TLR9-GFP in our study was
tagged at their C termini with enhanced GFP while previous study
indicates that the N-terminal site in TLR9 is responsible for CpG-
DNA recognition and activation [37].
The B-class oligonucleotide (ODN) used in our study as a model
ligand forms stable monomer constructs instead. Therefore,
although we have established the stoichiometry of the ligand
binding to TLR9 through 2dPCH, the exact stoichiometry of
DNA molecules could vary with the type of TLR9 ligand. Based
on our results, which demonstrate that the CpG and non-CpG PS
DNA have the same stoichiometry with TLR9 but with different
binding affinity, it implies that the CpG and non CpG DNA might
bind to different sites of TLR9. However, the location of the
binding sites can only be confirmed from crystal structures of
DNA-TLR9 binding domain, which is beyond the scope of our
study.
In conclusion, we demonstrate a binding model based on
quantitative estimates of the binding affinity of TLR9 dimers with
CpG and non CPG DNA sequences in live HEK 293 cells. A
multiparameter single molecule fluorescence platform was estab-
lished to study the dynamics of the TLR9-ligand complex and
define their stoichiometry at single cell resolution. We expect our
findings to not only help further the understanding of TLR9
interactions in vivo but also to provide new insights towards the
design and characterization of TLR9-based therapeutics for the
treatment of autoimmune diseases or cancer.
Materials and Methods
TLR9 ligands
The phosphorothioate (PS) backbone CpG and non CpG DNA
bearing the respective sequences, 59-TCGTCGTTTTGTCGTT
TTGTCGTT-39 and 59-TGCTGCTTGTGCTTTTGTGCT
T-39 were commercially purchased (IDT, Coralville, IA). The
DNA was labeled with single Cy5 fluorophore at the 39 end.
Plasmid construction
To generate the CFP-CFP tandem construct, the coding
sequence of enhanced CFP was PCR-amplified using 59-aaa aga
tct ccA TGG TGA GCA AGG GCG AGG-39 and 59-cgc tcg aga
CTT GTA CAG CTC GTC CAT GCC G-39 oligonucleotides,
digested with BglII and XhoI, and ligated into the corresponding
sites of a CFP-containing pHA-CMV vector (a kind gift from Dr.
Hu, Purdue University). A GGGGSGGGGSGGGGS linker was
Figure 4. TLR9-CpG and TLR9-non-CpG has different mobility.
(a) Fraction of the binding complex estimated from FCCS cross-
correlation measurements, as a percentage of species in lower
concentration of the two binding partners. Data is expressed as the
mean with standard error (n=15). (b) MEMFCS analysis of FCCS data
shows the distribution of diffusion time in the binding complex in live
HEK 293 cells.
doi:10.1371/journal.pone.0017991.g004
Figure 5. Stoichiometry of TLR9-ligand complex in vivo. Binding
stoichiometry of TLR9-GFP with CpG-Cy5 and non CpG-Cy5 calculated
from the two-dimensional PCH analysis of fluorescence fluctuation data.
Data is expressed as the mean with standard deviation (n=10).
doi:10.1371/journal.pone.0017991.g005
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was verified by DNA sequencing.
TLR9 (GenBank
TM accession number AF259262) tagged at
their C termini with enhanced green fluorescent protein (EGFP)
was obtained from Dr. David M. Segal (National Cancer Institute,
Bethesda, MD) [38]. pEGFP-N1 was purchased from Clontech
(Mountainview, CA).
Cell culture
HEK 293 cells were grown in RPMI-1640 (ATCC) media with
10% fetal bovine serum and maintained at 37uC with 5% CO2.
For living-cell experiments, cells were seeded onto sterilized No. l
coverslip (VWR International, Batavia, IL) and placed in a 6-well
plate. TLR9-GFP and EGFP pDNA was transfected using 1 mL
Lipofectamine 2000 (Invitrogen, Carlsbad, CA), according to
manufacturer’s specifications. The amount of DNA used per well
was 500 ng of EGFR-GFP.
Single-molecule fluorescence instrument
All the single molecule fluorescence experiments were per-
formed with a time-resolved confocal fluorescence scope fitted
with picosecond lasers (465 nm and 636 nm at 20 MHz) and
optics for single molecule fluorescence spectroscopy and lifetime
imaging (Microtime 200, Picoquant, Berlin, Germany). Details of
the instrumentation are provided elsewhere [17,20]. The effective
confocal volume (Veff = p
3/2v
2z) calculated for the 465 nm and
636 nm excitation from the autocorrelation fitting functions for
Rhodamine 123 (300 um
2/s) and Atto 655 (390 um
2/s) dyes
(Invitrogen Molecular Probes Eugene, OR) were 0.36 fL and 1 fL,
respectively.
Fluorescence lifetime imaging (FLIM)
Fluorescence lifetime imaging was measured using the time
correlated single photon counting (TCSPC) module in the time-
tagged time-resolved (TTTR) mode. Fluorescence lifetime was
obtained by fitting the TCSPC histograms with the multi-
exponential model.
It ðÞ ~
X n
i~1
a1exp {
t
ti
  
ð1Þ
Where ti denote the lifetime with amplitudes ai corresponding to
component i. The values of ti and ai were obtained through
nonlinear least-squares fitting with the SymphoTime software
(PicoQuant GmbH Berlin, Germany) and the goodness of fit was
determined by x
2 value.
FCS and FCCS
Fluorescence fluctuation, dI(t) around the average fluorescence
,I. were recorded in real time and the normalized autocorre-
lation was calculated from:
G t ðÞ ~
SdIt ðÞ |dIt zt ðÞ T
SIt ðÞ T
2 ð2Þ
dI(t)=I(t)-,I(t).. The autocorrelation curve of fluorophore
diffusing in solution was fitted to a 3D diffusion model using
one or two components with the SymphoTime software and
Origin Lab using the equation:
G t ðÞ ~
X 1
Ni
1z
t
tDi
   {1
1z
t
tDi|k2
   {1
2
ð3Þ
Where, Ni and tDi denote the number of fluorescent molecules in
the detection volume and diffusion time of component i,
respectively. The parameter ‘k’ and the lateral diffusion coefficient
‘D’ can be obtained from:
k~
z0
v0
, D~
v0
2
4tD
ð4Þ
Here, k is defined as the ratio of the axial beam size z and radius v
of the laser, and tD denote the diffusion time of the fluorophore.
Autocorrelation of TLR9-GFP in live cells was calculated using
an anomalous diffusion model to fit the data as observed in the
cytoplasm [28].
G t ðÞ ~
1
N
1z
t
tD
   a    {1
1z
1
k2
t
tD
   a    {1
2
ð5Þ
Where a represents the degree of anomalous behaviour.
For dual color cross-correlation measurement, the 465 nm and
636 nm excitation were used to respectively excite the green and
red fluorophores and the cross-correlation function was calculated
from,
Gt ðÞ ~
SCijT
veff CizCij
  
CjzCij
   1z
t
tDi
   {1
1z
t
tDi|k2
   {1
2
ð6Þ
Here ,Ci., ,Cj., and ,Cij. denote the concentration of
species i, j, and ij (depicting the bound species), respectively, and
Veff is the effective detection volume for the dual color experiment.
Using these considerations, the diffusion time and the effective
detection volume for cross-correlation analysis can be estimated
from,
tD~
v2
i zv2
j
8Dij
,veff~
p
3= 2 v2
i zv2
j
  
Z2
i zZ2
j
  
2
3= 2
ð7Þ
Where Dij is the diffusion coefficient of the bound molecule and its
concentration can be obtained from the cross-correlation analysis
as,
SCijT~
Gij 0 ðÞ
Gi 0 ðÞ Gj 0 ðÞ veff
ð8Þ
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Gi(0) and Gj(0) are the respective autocorrelation amplitudes of
species i and j at time t=0.
The fraction of bound complex was calculated as a percentage
of the lower concentration species (Ci or Cj) according to the
following equation:
SCijT
SCiTorSCjT
ð9Þ
MEMFCS
MEMFCS (Maximum Entropy Method analysis of Fluores-
cence Correlation Spectroscopy data) [30] was employed to
validate the cross-correlation diffusion time distribution. The
analysis is based on minimizing the x
2 value and maximizing the
entropy S to obtain an optimal fit when species with different
diffusion times are involved. G(t) in Eq 3, can be rewritten to
obtain a continuous distribution of diffusion times as:
G t ðÞ ~
ð
a 1z
t
tD
   {1
1z
t
tD|k2
   {1
2
dtD ð10Þ
S is defined as, S~
X
i
PiIn Pi ðÞ , where P~ai=
P
ai.
PCH and 2dPCH
For one-dimensional PCH analysis, data was arranged as a
histogram comprising of the number of photon events per unit
time with a bin size of 50 ms. From the histogram, molecular
brightness and concentration of molecules were extracted [39].
The autofluorescence from live cells was taken into consideration
as the background during analysis. A one (i=1) or two component
model (i=2) was used to fit the data depending upon the x
2 value
using the PCH and 2dPCH software [34]. The values depicting
the brightness of GFP monomer and GFP dimer were fixed and
the data was fitted globally to two components to determine the
percentage of TLR9 monomers and dimers.
For 2dPCH analysis, the data was arranged in the form of two-
dimensional histogram of counts as a function of frequency with a
bin size of 50 ms, optimized for this experiment. The binding data
of TLR9 and DNA was fitted with a single component and an F-
test was used for parameter optimization when fitting for more
than one component.
Supporting Information
Figure S1 TLR9-GFP and GFP has different fluorescence
lifetime. (a) Distribution pattern of GFP and TLR9-GFP by
confocal fluorescence lifetime imaging. (b) GFP and TLR9-GFP
lifetime distribution histogram corresponding to the two images in
(a). Lifetime pseudo color bar: 0 to 5 ns. Scale bar: 10 mm.
(TIF)
Figure S2 FCS evaluation of GFP and TLR9-GFP. Autocorre-
lation curves of cytosolic GFP (red square) and TLR9-GFP (blue
square) and the best fit curves (black). Cytosolic GFP was fitted
with a 3D diffusion model (Eq 3.) while TLR9-GFP was fitted with
the anomalous model (Eq 5).
(TIF)
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